Symposium

Katherine Wang – Singapore Therapeutics Development Review (STDR)

Kantharaj Ethirajulu – Preclinical Development

Hannes Hentze – Preclinical In Vivo Studies

Michael Wong – The Importance of Developing a Biomarker & Translational Strategy in Early Drug Discovery

Detlev Mennerich – Starting w/ the End in Mind 1: Boehringer Ingelheim’s Approach to External Innov.

Snow Lee – New Horizons in Antibody Modalities for Targeted Therapy

Wan Kah Fei – Exploring the Realm of Large Molecule Drugs: From Target to Lead Perspective

Lim Wan Hsin – Targeting RNA with Small Molecules

Klement Foo – Emerging Small Molecule Approaches

Joseph Cherian – A Hit is Not a Lead: A Medicinal Chemist’s Perspective